Georg Greiner, Michael Gurbisz, Franz Ratzinger, Nadine Witzeneder, Svenja Verena Class, Gregor Eisenwort, Ingrid Simonitsch-Klupp, Harald Esterbauer, Matthias Mayerhofer, Leonhard Müllauer, Wolfgang R. Sperr, Peter Valent, Gregor Hoermann. Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis. haematol [Internet]. 2020Jan.31 [cited 2024Apr.25];105(2):366-74. Available from: https://haematologica.org/article/view/9521